Cargando…

Crosstalk between Metabolic Disorders and Immune Cells

Metabolic syndrome results from multiple risk factors that arise from insulin resistance induced by abnormal fat deposition. Chronic inflammation owing to obesity primarily results from the recruitment of pro-inflammatory M1 macrophages into the adipose tissue stroma, as the adipocytes within become...

Descripción completa

Detalles Bibliográficos
Autores principales: Saitoh, Shinichi, Van Wijk, Koen, Nakajima, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469678/
https://www.ncbi.nlm.nih.gov/pubmed/34576181
http://dx.doi.org/10.3390/ijms221810017
_version_ 1784573996228935680
author Saitoh, Shinichi
Van Wijk, Koen
Nakajima, Osamu
author_facet Saitoh, Shinichi
Van Wijk, Koen
Nakajima, Osamu
author_sort Saitoh, Shinichi
collection PubMed
description Metabolic syndrome results from multiple risk factors that arise from insulin resistance induced by abnormal fat deposition. Chronic inflammation owing to obesity primarily results from the recruitment of pro-inflammatory M1 macrophages into the adipose tissue stroma, as the adipocytes within become hypertrophied. During obesity-induced inflammation in adipose tissue, pro-inflammatory cytokines are produced by macrophages and recruit further pro-inflammatory immune cells into the adipose tissue to boost the immune response. Here, we provide an overview of the biology of macrophages in adipose tissue and the relationship between other immune cells, such as CD4+ T cells, natural killer cells, and innate lymphoid cells, and obesity and type 2 diabetes. Finally, we discuss the link between the human pathology and immune response and metabolism and further highlight potential therapeutic targets for the treatment of metabolic disorders.
format Online
Article
Text
id pubmed-8469678
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84696782021-09-27 Crosstalk between Metabolic Disorders and Immune Cells Saitoh, Shinichi Van Wijk, Koen Nakajima, Osamu Int J Mol Sci Review Metabolic syndrome results from multiple risk factors that arise from insulin resistance induced by abnormal fat deposition. Chronic inflammation owing to obesity primarily results from the recruitment of pro-inflammatory M1 macrophages into the adipose tissue stroma, as the adipocytes within become hypertrophied. During obesity-induced inflammation in adipose tissue, pro-inflammatory cytokines are produced by macrophages and recruit further pro-inflammatory immune cells into the adipose tissue to boost the immune response. Here, we provide an overview of the biology of macrophages in adipose tissue and the relationship between other immune cells, such as CD4+ T cells, natural killer cells, and innate lymphoid cells, and obesity and type 2 diabetes. Finally, we discuss the link between the human pathology and immune response and metabolism and further highlight potential therapeutic targets for the treatment of metabolic disorders. MDPI 2021-09-16 /pmc/articles/PMC8469678/ /pubmed/34576181 http://dx.doi.org/10.3390/ijms221810017 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Saitoh, Shinichi
Van Wijk, Koen
Nakajima, Osamu
Crosstalk between Metabolic Disorders and Immune Cells
title Crosstalk between Metabolic Disorders and Immune Cells
title_full Crosstalk between Metabolic Disorders and Immune Cells
title_fullStr Crosstalk between Metabolic Disorders and Immune Cells
title_full_unstemmed Crosstalk between Metabolic Disorders and Immune Cells
title_short Crosstalk between Metabolic Disorders and Immune Cells
title_sort crosstalk between metabolic disorders and immune cells
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469678/
https://www.ncbi.nlm.nih.gov/pubmed/34576181
http://dx.doi.org/10.3390/ijms221810017
work_keys_str_mv AT saitohshinichi crosstalkbetweenmetabolicdisordersandimmunecells
AT vanwijkkoen crosstalkbetweenmetabolicdisordersandimmunecells
AT nakajimaosamu crosstalkbetweenmetabolicdisordersandimmunecells